Is there still a role for recombinant erythropoietin in the management of anaemia of critical illness?;¿eritropoyetina humana recombinante, ¿una alternativa válida para el tratamiento de la anemia del paciente crítico?

Medicina Clinica

Volumn 132, Issue 19, 2009, Pages 749-755

  Muñoz, Manuel ^a   Ramón Leal Noval, Santiago ^b   García Erce, José Antonio ^c  

^a UNIVERSIDAD DE MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

Allogeneic blood transfusion; Anaemia; Critically ill patients; Functional iron deficiency; Iv iron; Recombinant human erythropoietin; Thromboprophylaxis

Indexed keywords

IRON; RECOMBINANT ERYTHROPOIETIN;

ALLOTRANSPLANTATION; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CRITICAL ILLNESS; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; IRON THERAPY; MORBIDITY; MORTALITY; NERVOUS SYSTEM INJURY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT MONITORING; PREVALENCE; RISK FACTOR; THERAPY EFFECT; TREATMENT INDICATION;

EID: 67649529319     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2008.11.019     Document Type: Review

References (55)

1. H.L. Corwin, A. Gettinger, R.G. Pearl, M.P. Fink, M.M. Levy, and E. Abraham The CRIT study: Anaemia and blood transfusion in the critically ill - current clinical practice in the United States Crit Care Med 32 2004 39 52
2. J.L. Vincent, J.F. Baron, K. Reinhart, L. Gattinoni, L. Thijs, and A. Webb Anaemia and blood transfusion in critically ill patients JAMA 288 2002 1499 1507
3. T.S. Walsh, R.J. Lee, C.R. MacIver, M. Garrioch, F. MacKirdy, and A.R. Binning Anaemia during and at discharge from intensive care: The impact of restrictive blood transfusion practice Intensive Care Med 32 2006 100 109
4. P.C. Hébert, G. Wells, C. Martín, M. Tweeddale, J. Marshall, and M. Blajchman Variation in red cell transfusion practice in the intensive care unit: a multicentre cohort study Crit Care 3 1999 57 63
5. P.E. Marik, and W.J. Sibbald Effect of stored-blood transfusion on oxygen delivery in patients with sepsis JAMA 269 1993 3024 3029
6. T. Walsh, F. McArdle, S. McLellan, C. Maciver, M. Maginnis, and R. Prescott Does the storage time of transfused red blood cells influence regional or global indexes of tissue oxygenation in anemic critically ill patients? Crit Care Med 32 2004 364 371
7. M.J. Smith, M.F. Stiefel, S. Magge, S. Frangos, S. Blom, and V. Gracias Packed erythrocytes transfusion increases local cerebral oxygenation Crit Care Med 33 2005 1104 1108
8. S.R. Leal-Noval, M.D. Rincón-Ferrari, A. Marin-Niebla, A. Cayuela, V. Arellano-Orden, and A. Marín-Caballos Transfusion of erythrocyte concentrates produces a variable increment on cerebral oxygenation in patients with severe traumatic brain injury Intensive Care Med 32 2006 1733 1740
9. S.R. Leal-Noval, M. Muñoz-Gómez, V. Arellano-Orden, A. Marín-Caballos, R. Amaya-Villar, and A. Marín Impact of age of transfused blood on cerebral oxygenation in male patients with severe traumatic brain injury Crit Care Med 38 2008 1290 1296
10. S.R. Leal-Noval, M.D. Rincón-Ferrari, A. García-Curiel, A. Herruzo-Avilés, P. Camacho-Laraña, and J. Garnacho-Montero Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery Chest 119 2001 1461 1468
11. S.R. Leal-Noval, I. Jara-López, J.L. García-Garmendia, A. Marín-Niebla, A. Herruzo-Avilés, and P. Camacho-Laraña Influence of erythrocyte concentrate storage time on postsurgical morbidity in cardiac surgery patients Anesthesiology 98 2003 815 822
12. C.G. Koch, L. Li, D.I. Sessler, P. Figueroa, G.A. Hoeltge, and T. Mihaljevic Duration of red-cell storage and complications after cardiac surgery N Engl J Med 358 2008 1229 1239
13. P.E. Marik, and H.L. Corwin Efficacy of red blood cell transfusion in the critically ill: A systematic review of the literature Crit Care Med 36 2008 1 9
14. J.L. Vincent, Y. Sakr, C. Sprung, S. Harboe, P. Damas on behalf of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Investigators Are blood transfusions associated with greater mortality rates? Results of the Sepsis Occurrence in Acutely Ill Patients study Anesthesiology 108 2008 31 39
15. G.A. Nutall, and T.T. Houle Liars, damn liars, and propensity scores Anesthesiology 108 2008 3 4
16. P.C. Hébert, G. Wells, M.A. Blajchman, J. Marshall, C. Martin, and G. Pagliarello A multicenter, randomized, controlled clinical trial of tranfusion requeriments in critical care N Engl J Med 340 1999 409 417
17. K. Deans, P.C. Minneci, A.F. Suffredini, R.L. Danner, W.D. Hoffman, and X. Ciu Randomization in clinical trials of titrated therapies: Unintended consequences of using fixed treatment protocols Crit Care Med 35 2007 1509 1516
18. C. Natanson, S.J. Kern, P. Lurie, S.M. Banks, and S.M. Wolfe Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death. A meta-analysis JAMA 299 2008 2304 2312
19. M. Muñoz, S.R. Leal-Noval, J.A. García-Erce, and E. Naveira Prevalencia y manejo de la anaemia en el paciente crítico Medicina Intensiva 31 2007 388 398
20. J.M. Still Jr, K. Belcher, E.J. Law, W. Thompson, M. Jordan, and M. Lewis A double-blinded prospective evaluation of recombinant human erythropoietin in acutely burned patients J Trauma 38 1995 233 236
21. A. Gabriel, S. Kozek, A. Chiari, R. Fitzgerald, C. Grabner, and K. Geissler High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome J Trauma 44 1998 361 367
22. H.L. Corwin, A. Gettinger, R.M. Rodriguez, R.G. Pearl, K.D. Gubler, and C. Enny Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial Crit Care Med 27 1999 2346 2350
23. C.E. Van Iperen, C.A. Gaillard, R.J. Kraaijenhagen, B.G. Braam, J.J. Marx, and A. Van de Wiel Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients Crit Care Med 28 2000 2773 2778
24. H.L. Corwin, A. Gettinger, R.G. Pearl, M.P. Fink, M.M. Levy, and M.J. Shapiro Efficacy of recombinant human erythropoietin in critically ill patients: A ramdomized, controlled trial JAMA 288 2002 2827 2835
25. D. Georgopoulos, D. Matamos, C. Routsi, A. Michalopoulos, N. Margina, and G. Dimopoulos Recombinant human erythropoietin therapy in critically ill patients: A dose-response study Crit Care 9 2005 R508 R515
26. M. Silver, M.J. Corwin, A. Bazan, A. Gettinger, C. Enny, and H.L. Corwin Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: A randomized, double-blind, placebo-controlled trial Crit Care Med 34 2006 2310 2316
27. J.L. Vincent, H.D. Spapen, J. Creteur, M. Piagnarelli, I. Hubloue, and M. Diltoer Pharmacokinetics and pharmacodynamics of one-weekly subcutaneous epoetin alfa in critically ill patients: Results of a randomized, double blind, placebo-controlled trial Crit Care Med 34 2006 1661 1667
28. H.L. Corwin, A. Gettinger, T.C. Fabian, A. May, R.G. Pearl, and S. Heard Efficacy and safety of epoetin alfa in critically ill patients New Engl J Med 357 2007 965 976
29. R. Zarychansky, A.B. Turgeron, L. McIntyre, and D.A. Fergusson Erythropoietin-receptor agonist in critical ill patients: A meta-analysis of randomised controlled trials CMAJ 177 2007 725 734
30. S.A. Voils, S.H. Harpe, and G.M.l. Brophy Comparison of dardepoetin alpha and epoetin alpha in the management of anaemia of critical illness Pharmacotherapy 27 2007 535 541
31. W.H. Geerts, D. Bergqvist, G.F. Pineo, J.A. Heit, C.M. Samama, and M.R. Lassen Prevention of venous thromboembolism: American college of chest physicians evidence-based clinical practice guidelines (8th edition) Chest 133 2008 381S 453S
32. A. Mikhail Epoetin alfa in critically ill patients N Engl J Med 357 2007 2515
33. Y. Beguin Erythropoietin and platelet production Haematologica 84 1999 541 547
34. N. Von Ahsen, C. Muller, S. Serke, U. Frei, and K.U. Eckardt Important role of nondiagnostic blood loss and blunted erythropoietic response in the anaemia of medical intensive care patients Crit Care Med 27 1999 2630 2639
35. P. Rogiers, H. Zhang, M. Leeman, J. Nagler, H. Neels, and C. Melot Erythropoietin response is blunted in critically ill patients Crit Care Med 23 1997 159 162
36. P. Hobisch-Hagen, F. Wiedermann, A. Mayr, D. Fries, W. Jelkman, and D. Fuchs Blunted erythropoietic reponse to anaemia in multiply traumatized patients Crit Care Med 29 2001 743 747
37. F.M. Pieracci, and P.S. Barie Diagnosis and management of iron-related anaemias in critical illness Crit Care Med 34 2006 1898 1905
38. M. Muñoz, A. Romero, M. Morales, A. Campos, J.A. García-Erce, and G. Ramírez Iron metabolism, inflammation and anaemia in critically ill patients. A cross-sectional study Nutr Hosp 20 2005 115 120
39. M.C. Bellamy, and J.A. Gednaey Unrecognised iron deficiency in critical illness Lancet 352 1998 1903
40. M. Muñoz, C. Breymann, J.A. García-Erce, S. Gómez-Ramírez, J. Comin, and E. Bisbe Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood transfusion Vox Sang 94 2008 172 183
41. T. Kapoian, N.B. O'Mara, A.K. Singh, J. Moran, A.R. Rizkala, and R. Geronemus Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin J Am Soc Nephrol 19 2008 372 379
42. C.L. Bennett, S.M. Silver, B. Djulbegovic, A.T. Samaras, C.A. Blau, and H.J. Gleason Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia JAMA 299 2008 914 924
43. N.V. Dahl, D.H. Henry, and D.W. Coyne Thrombosis with erythropoietic stimulating agents-does iron-deficient erythropoiesis play a role? Semin Dial 21 2008 210 211
44. T.S. Walsh, and E.-E.-D. Saleh Anaemia during critical illness Br J Anaesth 97 2006 278 291
45. J.A. García-Erce, J. Cuenca, M. Muñoz, M. Izuel, A.A. Martínez, and A. Herrera Perioperative stimulation of erythropoiesis with intravenous iron and erythropoietin reduces transfusion requirements in patients with hip fracture. A prospective observational study Vox Sang 88 2005 235 243
46. G. Chen, J.X. Shi, C.H. Hang, W. Xie, J. Liu, and X. Liu Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: A potential neuroprotective mechanism of recombinant human erythropoietin (rhuEPO) Neurosci Letters 425 2007 177 182
47. G. Grasso, A. Sfacteria, F. Meli, V. Fodale, M. Buemi, and D.G. Iacopino Neuroprotection by erythropoietin administration after experimental traumatic brain injury Brain Res 1182 2007 99 105
48. Y. Xiong, A. Mahmood, D. Lu, C. Qu, A. Goussev, and T. Schallert Role of gender in outcome after traumatic brain injury and therapeutic effect of erythropoietin in mice Brain Res 1185 2007 301 312
49. J.W. Schonten Neuroprotection in traumatic brain injury: A complex struggle against the biology of nature Curr Opin Crit Care 13 2007 134 142
50. H. Ehrenreich, M. Hasselblat, C. Dembowski, L. Cepek, P. Lewczuk, and M. Stiefel Erythropoietin therapy for acute stroke is both safe and beneficial Mol Med 8 2002 495 505
51. FDA alert. Early communication about an ongoing safety review Epoetin alfa. September 23, 2008. http://www.fda.gov/cder/drug/early-comm/epoetin-alfa. htm.
52. E.B. Milbrandt, G. Clermont, J. Martínez, A. Kersten, M.T. Rahim, and D.C. Angus Predicting late anaemia in critical illness Crit Care 10 2006 R39
53. A. Phrommintikul, S.J. Haas, M. Elsik, and H. Krum Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: A meta-analysis Lancet 369 2007 381 388
54. European Medicines Agency (EMEA). Public Statement. Epoetins and the risk of tumour growth progression and thromboembolic events in cancer patients and cardiovascular risks in patients with chronic kidney disease. London, 23 October 2007. Doc. Ref. EMEA/496188/2007.
55. Ministerio de Sanidad y Consumo. Agencia Española de Medicamentos y Productos sanitarios. Nota informativa. Progresión tumoral, reducción de la supervivencia y riesgos cardiovasculares asociados a las epoetinas: nuevas recomendaciones de uso. 26 de junio de 2008.